| P2093 | author name string | M Muraine | |
| | V Langlois | |
| | Y Benhamou | |
| | C Ngo | |
| | H Levesque | |
| | Mathilde Leclercq | |
| | N Girszyn | |
| | J Gueudry | |
| | M Le Besnerais | |
| P2860 | cites work | Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment | Q26749730 |
| | Tocilizumab in severe and refractory non-infectious uveitis. | Q33417913 |
| | Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients | Q35763133 |
| | Birdshot uveitis: current and emerging treatment options | Q37412317 |
| | Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies. | Q38087452 |
| | Tocilizumab in rheumatoid arthritis: a meta-analysis of efficacy and selected clinical conundrums | Q38164973 |
| | Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema | Q38247504 |
| | Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. | Q38395263 |
| | TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA. | Q38777213 |
| | Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review. | Q38977592 |
| | Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients with Non-Infectious Uveitis | Q40059806 |
| | IL-6 blockade in the management of non-infectious uveitis | Q40204739 |
| | Tocilizumab treatment for refractory uveitis-related cystoid macular edema. | Q45903627 |
| | Regulatory T cells in blood of patients with birdshot retinochoroidopathy. | Q45909777 |
| | Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial | Q47863460 |
| | Adalimumab in Patients with Active Noninfectious Uveitis. | Q49025036 |
| | Interferon-alpha2a and Systemic Corticosteroid in Monotherapy in Chronic Uveitis: Results of the Randomized Controlled BIRDFERON Study. | Q50791508 |
| | [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment] | Q83021188 |
| | Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis | Q85039818 |
| | Outcome of tocilizumab treatment in refractory ocular inflammatory diseases | Q89053503 |
| P921 | main subject | uveitis | Q280027 |
| | tocilizumab | Q425154 |
| P577 | publication date | 2018-02-03 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review | |